Is the obesity drug market still a duopoly?
Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...
Ten signs you’re in the obesity danger zone
A new study claims there are two kinds of obesity – one of which puts you at risk of major health problems. Find out which ...